PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences (CAMS) and Comparative Medicine Center, Peking Union Medical College (PUMC), Key Laboratory of Human Disease Comparative Medicine, Chinese Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Reemerging Infectious Diseases, 5 Panjiayuan Nanli, Chaoyang District, Beijing 100021, PR China. Electronic address: kongqi@cnilas.org.\', \'Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences (CAMS) and Comparative Medicine Center, Peking Union Medical College (PUMC), Key Laboratory of Human Disease Comparative Medicine, Chinese Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Reemerging Infectious Diseases, 5 Panjiayuan Nanli, Chaoyang District, Beijing 100021, PR China.\', \'Medical College, Qingdao University, Qingdao 266071, PR China. Electronic address: chenxiu0725@qq.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0753-3322(20)30508-410.1016/j.biopha.2020.110316
?:hasPublicationType
?:journal
  • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
is ?:pmid of
?:pmid
?:pmid
  • 32505821
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Analysis of the molecular mechanism of Pudilan (PDL) treatment for COVID-19 by network pharmacology tools.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all